The store will not work correctly when cookies are disabled.
US8629135, SW-10
ID: ALA3693952
Cas Number: 2409-19-0
PubChem CID: 17001
Max Phase: Preclinical
Molecular Formula: C19H24N2
Molecular Weight: 280.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NCCCC1(CCCN)c2ccccc2-c2ccccc21
Standard InChI: InChI=1S/C19H24N2/c20-13-5-11-19(12-6-14-21)17-9-3-1-7-15(17)16-8-2-4-10-18(16)19/h1-4,7-10H,5-6,11-14,20-21H2
Standard InChI Key: YREZIWUCYDRMPK-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
1.5070 3.1041 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3096 2.2121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8463 0.7846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8502 -0.3311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3914 -2.8742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8596 -2.5631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8638 -3.6784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0378 -3.4297 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5701 -4.1788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0400 -5.5491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5318 -5.7059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4135 -4.4923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
5 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 5 1 0
21 16 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 280.42 | Molecular Weight (Monoisotopic): 280.1939 | AlogP: 3.43 | #Rotatable Bonds: 6 |
Polar Surface Area: 52.04 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.51 | CX LogP: 3.02 | CX LogD: -2.19 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.85 | Np Likeness Score: 0.30 |
References
1. (2014) Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer, |